Avinger, Inc. Stock

Equities

AVGR

US0537348775

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-05-07 pm EDT 5-day change 1st Jan Change
3.76 USD -1.31% Intraday chart for Avinger, Inc. +0.53% +38.75%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2024 * 10.5M Sales 2025 * 13.93M Capitalization 6.04M
Net income 2024 * -16M Net income 2025 * -14M EV / Sales 2024 * 0.58 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.43 x
P/E ratio 2024 *
-1.83 x
P/E ratio 2025 *
-2.82 x
Employees 70
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.31%
1 week+0.53%
Current month+0.53%
1 month+4.16%
3 months+41.09%
6 months+5.03%
Current year+38.75%
More quotes
1 week
3.59
Extreme 3.5923
3.94
1 month
3.42
Extreme 3.42
4.37
Current year
2.50
Extreme 2.5
5.45
1 year
2.50
Extreme 2.5
18.00
3 years
2.50
Extreme 2.5
438.00
5 years
2.50
Extreme 2.5
2 220.00
10 years
2.50
Extreme 2.5
1 000 000.00
More quotes
Managers TitleAgeSince
Founder 63 07-03-07
Chief Executive Officer 61 14-12-28
Director of Finance/CFO 41 19-12-31
Members of the board TitleAgeSince
Chief Executive Officer 61 14-12-28
Chairman 81 14-11-30
Director/Board Member 72 11-02-28
More insiders
Date Price Change Volume
24-05-06 3.81 -2.31% 5,129
24-05-03 3.9 +1.56% 10,223
24-05-02 3.84 +4.34% 4,837
24-05-01 3.68 -1.60% 3,866
24-04-30 3.74 -0.80% 6,576

Delayed Quote Nasdaq, May 07, 2024 at 04:00 pm EDT

More quotes
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.81 USD
Average target price
5 USD
Spread / Average Target
+31.23%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW